Following strong financial results revealed last month, US-headquartered Globus Medical has agreed to acquire spinal cord stimulation (SCS) company Nevro for $250m to reinforce its position in the ...

Nevro Corp is a medical device company. Its key product is the HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the ...

Nevro Corp. NVRO reported a ... are affected by ongoing softness in the U.S. SCS market and competitive pressures. Total U.S. permanent implant procedures, as well as U.S. trial procedures ...

U.S. permanent implant procedures decreased ... patient outcomes in chronic pain treatment. Nevro's comprehensive HFX™ spinal cord stimulation (SCS) platform includes the Senza® SCS system ...